GlassScriptPhysician profile
Ricardo V Bellera
NPI 1285860080
$17,071.49
in general payments reported to CMS, 2019-2025
42 companies · $3,126 in 2025
The $3,126 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,873 · 2020: $555 · 2021: $1,333 · 2022: $3,222 · 2023: $1,958 · 2024: $4,004 · 2025: $3,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,362 · Travel and Lodging: $2,599 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,362.12 |
| Travel and Lodging | $2,598.69 |
| Education | $127.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,633.23 | 2019-2025 | General - Vascular Access, Versacross Access Solution, Watchman Flx |
| Medtronic, INC. | $1,827.07 | 2021-2025 | Corevalve Evolut R, Venaseal, Harmony |
| Abbott Laboratories | $1,567.62 | 2019-2025 | Cardiomems, Aveir, Gallant |
| Edwards Lifesciences Corporation | $1,538.82 | 2019-2023 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $1,256.92 | 2019-2025 | |
| Abiomed | $915.82 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $685.60 | 2021-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $607.71 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $463.66 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $400.24 | 2019-2025 | Farxiga, Andexxa, Wainua |
| Impulse Dynamics (USA) INC. | $288.92 | 2022-2024 | Optimizer, Optimizer |
| Lexicon Pharmaceuticals, INC. | $285.28 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $238.43 | 2020-2025 | Camzyos, Eliquis |
| Biotronik INC. | $229.36 | 2022-2024 | Biomonitor |
| Medtronic Vascular, INC. | $222.28 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $200.22 | 2023-2025 | Inspire |
| Teleflex LLC | $136.11 | 2024 | Guideliner |
| Cvrx, INC. | $127.77 | 2022 | |
| Shockwave Medical, INC | $110.32 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.82 | 2022-2025 | Jardiance |
| Amgen INC. | $103.96 | 2021-2025 | Repatha, Repatha |
| Zoll Circulation INC | $100.49 | 2021-2022 | |
| Pfizer INC. | $97.27 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $94.99 | 2023 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.71 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $77.98 | 2022-2025 | |
| Azurity Pharmaceuticals, INC. | $71.90 | 2023-2024 | Edarbyclor, Edarbyclor |
| Tactile Systems Technology INC | $68.49 | 2022 | |
| Angiodynamics, INC. | $67.54 | 2022-2024 | Alphavac |
| Biosense Webster, INC. | $64.30 | 2022-2023 | Carto 3 |
| Siemens Medical Solutions USA, INC. | $50.00 | 2023 | Artis Q Biplane, Cios Alpha |
| Cook Medical LLC | $47.27 | 2021-2024 | Torcon Nb, Amplatz |
| Heartflow, INC. | $42.50 | 2022 | |
| Esperion Therapeutics, INC. | $41.89 | 2023 | Nexletol |
| Stryker Corporation | $39.83 | 2025 | Limflow System |
| Bard Peripheral Vascular, INC. | $34.98 | 2021 | |
| Sanofi-Aventis U.S. LLC | $34.56 | 2019-2022 | |
| Cashflow Solutions, LLC | $30.32 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Kestra Medical Technology Services, INC. | $25.98 | 2024 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $18.91 | 2025 | |
| Glaxosmithkline, LLC. | $16.67 | 2025 | Shingrix, Arexvy |
| Cardiovascular Systems INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Bellera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.